High-purity therapeutic APIs manufactured under strict cGMP protocols for global distribution.
In the rapidly evolving biopharmaceutical landscape, procuring high-purity Sermorelin Acetate Active Pharmaceutical Ingredients (APIs) requires a comprehensive understanding of synthesis standards, dosage parameters, stability profiles, and global supply chain resilience. Sermorelin—a synthetic 29-amino acid peptide corresponding to the amino-terminal segment of human Growth Hormone-Releasing Hormone (GHRH 1-29)—stimulates the anterior pituitary gland to secrete endogenous Human Growth Hormone (hGH). For clinical researchers, compounding pharmacies, and pharmaceutical formulators seeking reliable direct-from-factory procurement, mastering the nuances of Sermorelin dosage, batch reproducibility, and manufacturer verification is paramount.
Sermorelin Acetate acts as a secretagogue that preserves the natural physiological feedback loop of the hypothalamic-pituitary axis. Unlike exogenous hGH administration, which suppresses native hormone release and disrupts pituitary function, Sermorelin stimulates biological GH pulses in tandem with somatostatin modulation. Quality control parameters for commercial batch production require strict adherence to international standard bio-analysis.
| Parameter Metric | Specification Target | Analytical Test Method |
|---|---|---|
| Chemical Sequence | H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 | Mass Spectrometry (ESI-MS / MALDI-TOF) |
| Molecular Weight | 3357.88 g/mol | High-Resolution Mass Spectrometry |
| API Purity Standard | ≥ 98.0% to 99.5% (Custom Batch) | Reverse-Phase HPLC (RP-HPLC) |
| Acetate Content | 5.0% – 12.0% | Ion Chromatography / HPLC |
| Endotoxin Limit | < 5.0 EU/mg (Injectable Grade) | LAL Kinetic Chromogenic Test |
| Physical Appearance | White to off-white lyophilized sterile powder | Visual Inspection / Reconstitution Clarity |
When sourcing from global factory suppliers, pharmaceutical clients require clear guidelines regarding dosage formulations for downstream finished dosage form (FDF) compounding. Reconstitution, dosage titration, and bio-equivalence protocols must align with medical application standards:
Integrated into anti-aging and age-management regimes across North America and Europe. Sermorelin dosage regimens facilitate cellular repair, enhanced body composition, visceral lipid reduction, and cognitive revitalization without down-regulating pituitary receptors.
Utilized by clinical research institutes in East Asia and Latin America as an analytical diagnostic tool to evaluate pituitary somatotroph reserve capacity in children presenting idiopathic short stature or GHD.
Deployed in advanced orthopedic recovery centers to accelerate collagen synthesis, ligamentous tissue healing, and muscle tissue recovery via elevated systemic IGF-1 (Insulin-like Growth Factor 1) upregulation.
Gentolex leads modern peptide engineering by transitioning traditional liquid-phase methods toward high-efficiency Solid-Phase Peptide Synthesis (SPPS) hybrid systems.
Utilizing advanced automated synthesizer platforms ensuring step-wise coupling efficiency >99%, drastically minimizing racemization and truncated side-products.
Implementation of preparatory Reverse-Phase HPLC coupled with environmentally sustainable solvent recovery units, yielding batch consistency at industrial scales.
R&D initiatives exploring liposomal encapsulation, transdermal microneedle arrays, and sublingual nano-emulsion delivery to eliminate daily subcutaneous injections.
Global pharmaceutical procurement demands operational reliability, strict cost-efficiency, and uncompromised regulatory alignment. China's chemical synthesis infrastructure represents the backbone of the global active pharmaceutical ingredient supply chain. Within this ecosystem, Gentolex Group stands out as a preeminent supplier and custom manufacturing partner.
Gentolex operates an extensive overall factory construction area of 250,000 square meters designed under strict international cGMP standards. Our scalable facility guarantees seamlessly scalable, flexible, and cost-effective production capacity from pilot-scale laboratory batches (grams) to commercial-scale metric tons.
Every batch of Sermorelin API and custom peptide produced by Gentolex undergoes rigorous QA/QC release testing. We provide complete regulatory documentation packages including Certificate of Analysis (CoA), HPLC chromatograms, Mass Spectrometry profiles, DMF (Drug Master File) support, and ISO certifications to streamline clients' local health authority approvals.
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially establishing key operational representatives in Mexico and South Africa. Our main services focus on supplying high-grade peptide APIs and Custom Peptides, FDF (Finished Dosage Form) license out, Technical Support & Consultation, Product Line and Lab Setup, as well as comprehensive Sourcing & Supply Chain Solutions.


The international demand for secretagogue peptides like Sermorelin, Tesamorelin, and Ipamorelin has experienced exponential growth due to expanding wellness industries, preventative anti-aging medicine, and clinical research into metabolic disorders. However, navigating cross-border pharmaceutical trade involves strict compliance structures.
Focus on FDA 503A and 503B compounding pharmacy supply requirements. API suppliers must provide non-sterile active raw material possessing verified low endotoxin and heavy metal profiles for sterile compounding.
Adherence to EMA CEP/WC standards and strict CLP chemical classification. Specialized cold-chain logistics (2-8°C or -20°C temperature-controlled transport) are established for batch integrity.
Tailored logistics networks across Latin America (e.g., Mexico) and Africa (e.g., South Africa) ensuring seamless customs clearance, tariff optimization, and localized client consultation.










Explore our latest scientific technical updates on therapeutic peptides and active pharmaceutical ingredients.
Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient composed of the amino acid sequence TKPRPGP. Originally developed through neuropharmacological research...
View Article Details
As a professional Thymosin Beta-4 API manufacturer and supplier, we provide high-quality Thymosin Beta-4 peptide API solutions for biotechnology companies and pharmaceutical research organizations...
View Article Details
BPC-157 API is a synthetic pentadecapeptide gaining substantial scientific interest due to its potential biological activities related to tissue repair, GI protection, and angiogenesis...
View Article Details
With the continuous development of neuroscience and peptide technology, Semax—a synthetic peptide derived from an ACTH fragment—has attracted extensive investigation among researchers...
View Article Details
SS-31 API (Elamipretide, MTP-131) is a synthetic mitochondria-targeting tetrapeptide designed to bind cardiolipin in the inner mitochondrial membrane, supporting cellular bioenergetics...
View Article DetailsDirect technical insights regarding Sermorelin dosage, sourcing, purity, and manufacturing.
Explore our secondary portfolio of catalog peptides and specialty synthetic intermediate compounds.